Skip to content
Cultural Foundation
Author:
XellSmart bio
FDA Grants Fast Track Designation to Xellsmart Off-The-Shelf Cell Therapy for Parkinson’s Disease
August 4, 2026
Advances in Parkinson’s Disease Cell Therapy: XellSmart Launches a Multicenter Phase II Clinical Trial Following Encouraging Phase I Results
April 14, 2026